A purple and pink letter v on a white background.
February 5, 2019

Introducing Venus Heal™, A New Treatment Modality For Soft Tissue Injuries and Conditions

We are excited to announce the launch of our latest medical device, Venus Heal™, now cleared in the United States and Canada to treat soft tissue injuries and conditions* faster than conventional methods. With over 11,000 systems installed worldwide, we have expanded our suite of leading medical devices and incorporated our most advanced technology into this latest innovation. Venus Heal™ is intended to  relieve pain,  improve  blood circulation, and increase range of motion through the relief of muscle spasm.

Venus Heal™ is powered by innovative RP3 technology, which synergistically combines the benefits of Multi-Polar Radio Frequency (RF), Pulsed Electro Magnetic Fields (PEMF), and massage. In addition to its compact and portable design meant to adapt to a specialist’s needs in-clinic or on-site, Venus Heal™ also includes advanced technological features for superior patient comfort and consistent treatment efficacy:

  • Adjustable RF levels that deliver deep volumetric thermal energy to target tissue at therapeutic temperatures
  • PEMF-only (non-thermal) option for various applications
  • Two ergonomic handpieces that are ideal for manual massage techniques and application with or without heat
  • Advanced Connectivity Module (ACM), the latest data collection technology

"We are thrilled to be announcing the launch of Venus Heal™, namely because this state-of-the-art technology makes it an industry first for accelerated soft tissue healing," says Domenic Serafino, Chairman and Chief Executive Officer at Venus Concept. “Whether patients are athletes with acute injuries or workers with repetitive strain injury, Venus Heal™ offers the newest modality and a highly advanced solution for soft tissue injuries or conditions. Combined with Venus Concept's unique business model, our customers realize a higher ROI with low-risk ownership. It’s the perfect solution for all rehabilitation professionals."

Give your sports medicine or rehabilitation practice and your patients a competitive edge with Venus Heal™. Contact us today to learn more.

* Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction. In the U.S., Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. These indications enable the treatment of certain soft tissue injuries and conditions.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.